Google Translate Disclaimer

A number of pages on the Government of Saskatchewan's website have been professionally translated in French. These translations are identified by a yellow box in the right or left rail that resembles the link below. The home page for French-language content on this site can be found at:

Renseignements en Français

Where an official translation is not available, Google™ Translate can be used. Google™ Translate is a free online language translation service that can translate text and web pages into different languages. Translations are made available to increase access to Government of Saskatchewan content for populations whose first language is not English.

Software-based translations do not approach the fluency of a native speaker or possess the skill of a professional translator. The translation should not be considered exact, and may include incorrect or offensive language. The Government of Saskatchewan does not warrant the accuracy, reliability or timeliness of any information translated by this system. Some files or items cannot be translated, including graphs, photos and other file formats such as portable document formats (PDFs).

Any person or entities that rely on information obtained from the system does so at his or her own risk. Government of Saskatchewan is not responsible for any damage or issues that may possibly result from using translated website content. If you have any questions about Google™ Translate, please visit: Google™ Translate FAQs.

Settlement Reached With Purdue Pharma Canada For Opioid Damages

Released on June 29, 2022

Further to the Government of British Columbia's announcement this morning, opioid manufacturer Purdue Pharma Canada has agreed to a first of its kind settlement in which it will provide compensation to all federal, provincial and territorial governments in Canada, including Saskatchewan, for a portion of the damage opioid addiction has caused.

"Opioid manufacturers, distributors and consultants have a responsibility to provide compensation for their role in the suffering of the many Saskatchewan residents struggling with opioid addiction, and this settlement will assist in those efforts," Mental Health and Addictions Minister Everett Hindley said.  "While no amount of money will make up for the losses our community has suffered, the Government of Saskatchewan is committed to holding the opioid industry accountable for acts of alleged wrongdoing committed in the manufacture and distribution of opioid products."

The proposed Purdue Pharma Canada settlement totals $150 million in monetary benefits to be shared by the various levels of government in addressing opioid addictions.  While the agreement is subject to final approval by the courts, it is expected to be the largest governmental health claim settlement in Canadian history and the first time Purdue Pharma Canada has agreed to settle with a non-U.S. government.

This settlement was reached in the context of a proposed class action on behalf of all federal, provincial and territorial governments in Canada to recover health care costs that resulted from the alleged wrongful conduct of opioid manufacturers, distributors and their consultants. The suit alleges that these parties engaged in deceptive marketing practices resulting in increased rates of addiction and overdose.

Purdue Pharma Canada is just one among 40 manufacturers and distributors named in the class action.  As part of this settlement, Purdue Pharma Canada agrees to cooperate in the prosecution of other parties.

2021 saw the highest number of opioid-related harms on record in Saskatchewan.  A record $470 million was allocated to Mental Health and Addictions in the 2022-23 Provincial Budget, the largest budget allocation ever for the third consecutive year.


For more information, contact:

Phone: 306-787-4083

We need your feedback to improve Help us improve